Literature DB >> 21571908

Animal models of human respiratory syncytial virus disease.

Reinout A Bem1, Joseph B Domachowske, Helene F Rosenberg.   

Abstract

Infection with the human pneumovirus pathogen, respiratory syncytial virus (hRSV), causes a wide spectrum of respiratory disease, notably among infants and the elderly. Laboratory animal studies permit detailed experimental modeling of hRSV disease and are therefore indispensable in the search for novel therapies and preventative strategies. Present animal models include several target species for hRSV, including chimpanzees, cattle, sheep, cotton rats, and mice, as well as alternative animal pneumovirus models, such as bovine RSV and pneumonia virus of mice. These diverse animal models reproduce different features of hRSV disease, and their utilization should therefore be based on the scientific hypothesis under investigation. The purpose of this review is to summarize the strengths and limitations of each of these animal models. Our intent is to provide a resource for investigators and an impetus for future research.

Entities:  

Mesh:

Year:  2011        PMID: 21571908      PMCID: PMC3154630          DOI: 10.1152/ajplung.00065.2011

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  119 in total

1.  [Experimental RS virus infection of cotton rats. A viral and immunofluorescent study].

Authors:  R S Dreĭzin; L O Vyshnevetskaia; E E Bagdamian; O D Iankevich; L B Tarasova
Journal:  Vopr Virusol       Date:  1971 Nov-Dec

2.  Alternative mechanisms of respiratory syncytial virus clearance in perforin knockout mice lead to enhanced disease.

Authors:  S Aung; J A Rutigliano; B S Graham
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

Review 3.  Experimental respiratory syncytial virus infection in calves and lambs.

Authors:  E B Belknap; D K Ciszewski; J C Baker
Journal:  J Vet Diagn Invest       Date:  1995-04       Impact factor: 1.279

4.  Respiratory syncytial virus infection of human cord and adult blood monocytes and alveolar macrophages.

Authors:  F Midulla; Y T Huang; I A Gilbert; N M Cirino; E R McFadden; J R Panuska
Journal:  Am Rev Respir Dis       Date:  1989-09

5.  Age-dependent differences in the pathogenesis of bovine respiratory syncytial virus infections related to the development of natural immunocompetence.

Authors:  Adriaan F G Antonis; Marina C de Jong; Wim H M van der Poel; Robbert G van der Most; Norbert Stockhofe-Zurwieden; Tjeerd Kimman; Remco S Schrijver
Journal:  J Gen Virol       Date:  2010-06-16       Impact factor: 3.891

6.  Macrophage impairment underlies airway occlusion in primary respiratory syncytial virus bronchiolitis.

Authors:  Jennifer L Reed; Yambasu A Brewah; Tracy Delaney; Timothy Welliver; Timothy Burwell; Ebony Benjamin; Ellen Kuta; Alexander Kozhich; LuAnn McKinney; JoAnn Suzich; Peter A Kiener; Luis Avendano; Luis Velozo; Alison Humbles; Robert C Welliver; Anthony J Coyle
Journal:  J Infect Dis       Date:  2008-12-15       Impact factor: 5.226

7.  Function of the respiratory syncytial virus small hydrophobic protein.

Authors:  Sandra Fuentes; Kim C Tran; Priya Luthra; Michael N Teng; Biao He
Journal:  J Virol       Date:  2007-05-09       Impact factor: 5.103

Review 8.  Use of alternative animals as asthma models.

Authors:  Nathalie Kirschvink; Petra Reinhold
Journal:  Curr Drug Targets       Date:  2008-06       Impact factor: 3.465

9.  Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases.

Authors:  L Clark Paramore; Vincent Ciuryla; Gabrielle Ciesla; Larry Liu
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

10.  Comparison of cytokine responses in nasopharyngeal aspirates from children with viral lower respiratory tract infections.

Authors:  Jung Hye Byeon; Jin Chul Lee; Ic Sun Choi; Young Yoo; Sang Hee Park; Ji Tae Choung
Journal:  Acta Paediatr       Date:  2009-01-13       Impact factor: 2.299

View more
  96 in total

1.  Acute and Chronic Airway Disease After Human Respiratory Syncytial Virus Infection in Cotton Rats (Sigmodon hispidus).

Authors:  Jessica L Grieves; Zhiwei Yin; Russell K Durbin; Joan E Durbin
Journal:  Comp Med       Date:  2015-08       Impact factor: 0.982

2.  Immortalized MH-S cells lack defining features of primary alveolar macrophages and do not support mouse pneumovirus replication.

Authors:  Todd A Brenner; Tyler A Rice; Erik D Anderson; Caroline M Percopo; Helene F Rosenberg
Journal:  Immunol Lett       Date:  2016-02-23       Impact factor: 3.685

3.  Critical Adverse Impact of IL-6 in Acute Pneumovirus Infection.

Authors:  Caroline M Percopo; Michelle Ma; Todd A Brenner; Julia O Krumholz; Timothy J Break; Karen Laky; Helene F Rosenberg
Journal:  J Immunol       Date:  2018-12-21       Impact factor: 5.422

4.  Pathogen recognition receptor crosstalk in respiratory syncytial virus sensing: a host and cell type perspective.

Authors:  Nico Marr; Stuart E Turvey; Nathalie Grandvaux
Journal:  Trends Microbiol       Date:  2013-10-09       Impact factor: 17.079

5.  Immunobiotic Lactobacillus administered post-exposure averts the lethal sequelae of respiratory virus infection.

Authors:  Caroline M Percopo; Tyler A Rice; Todd A Brenner; Kimberly D Dyer; Janice L Luo; Kishore Kanakabandi; Daniel E Sturdevant; Stephen F Porcella; Joseph B Domachowske; Jesse D Keicher; Helene F Rosenberg
Journal:  Antiviral Res       Date:  2015-07-02       Impact factor: 5.970

Review 6.  Lamb model of respiratory syncytial virus-associated lung disease: insights to pathogenesis and novel treatments.

Authors:  Mark R Ackermann
Journal:  ILAR J       Date:  2014

7.  A Review of the CD4+ T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population.

Authors:  Ravi S Misra
Journal:  EC Microbiol       Date:  2014

8.  Activated mouse eosinophils protect against lethal respiratory virus infection.

Authors:  Caroline M Percopo; Kimberly D Dyer; Sergei I Ochkur; Janice L Luo; Elizabeth R Fischer; James J Lee; Nancy A Lee; Joseph B Domachowske; Helene F Rosenberg
Journal:  Blood       Date:  2013-12-02       Impact factor: 22.113

9.  Sustained inflammation and differential expression of interferons type I and III in PVM-infected interferon-gamma (IFNγ) gene-deleted mice.

Authors:  Stephanie F Glineur; Aaron B Bowen; Caroline M Percopo; Katia E Garcia-Crespo; Kimberly D Dyer; Sergei I Ochkur; Nancy A Lee; James J Lee; Joseph B Domachowske; Helene F Rosenberg
Journal:  Virology       Date:  2014-08-28       Impact factor: 3.616

10.  B cells are not essential for Lactobacillus-mediated protection against lethal pneumovirus infection.

Authors:  Caroline M Percopo; Kimberly D Dyer; Katia E Garcia-Crespo; Stanislaw J Gabryszewski; Arthur L Shaffer; Joseph B Domachowske; Helene F Rosenberg
Journal:  J Immunol       Date:  2014-04-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.